232 related articles for article (PubMed ID: 22132731)
1. Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion.
Sankpal NV; Mayfield JD; Willman MW; Fleming TP; Gillanders WE
Breast Cancer Res; 2011; 13(6):R124. PubMed ID: 22132731
[TBL] [Abstract][Full Text] [Related]
2. EpCAM modulates NF-κB signaling and interleukin-8 expression in breast cancer.
Sankpal NV; Fleming TP; Gillanders WE
Mol Cancer Res; 2013 Apr; 11(4):418-26. PubMed ID: 23378578
[TBL] [Abstract][Full Text] [Related]
3. Unfolded protein response mediated JNK/AP-1 signal transduction, a target for ovarian cancer treatment.
Zheng GF; Cai Z; Meng XK; Zhang Y; Zhu W; Pang XY; Dou L
Int J Clin Exp Pathol; 2015; 8(6):6505-11. PubMed ID: 26261528
[TBL] [Abstract][Full Text] [Related]
4. JNK-Dependent cJun Phosphorylation Mitigates TGFβ- and EGF-Induced Pre-Malignant Breast Cancer Cell Invasion by Suppressing AP-1-Mediated Transcriptional Responses.
Sundqvist A; Voytyuk O; Hamdi M; Popeijus HE; van der Burgt CB; Janssen J; Martens JWM; Moustakas A; Heldin CH; Ten Dijke P; van Dam H
Cells; 2019 Nov; 8(12):. PubMed ID: 31766464
[TBL] [Abstract][Full Text] [Related]
5. Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.
Martowicz A; Spizzo G; Gastl G; Untergasser G
BMC Cancer; 2012 Oct; 12():501. PubMed ID: 23110550
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion.
Sankpal NV; Willman MW; Fleming TP; Mayfield JD; Gillanders WE
Cancer Res; 2009 Feb; 69(3):753-7. PubMed ID: 19141643
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by AP1-dependent EpCAM expression in MCF-7 cells.
Gao J; Yan Q; Wang J; Liu S; Yang X
J Cell Physiol; 2015 Apr; 230(4):775-82. PubMed ID: 25205054
[TBL] [Abstract][Full Text] [Related]
8. Deglycosylation of epithelial cell adhesion molecule affects epithelial to mesenchymal transition in breast cancer cells.
Liu X; Yang L; Zhang D; Liu T; Yan Q; Yang X
J Cell Physiol; 2019 Apr; 234(4):4504-4514. PubMed ID: 30246502
[TBL] [Abstract][Full Text] [Related]
9. By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasis.
Gao J; Liu X; Yang F; Liu T; Yan Q; Yang X
Oncotarget; 2015 Sep; 6(29):27187-98. PubMed ID: 26356670
[TBL] [Abstract][Full Text] [Related]
10. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.
Osta WA; Chen Y; Mikhitarian K; Mitas M; Salem M; Hannun YA; Cole DJ; Gillanders WE
Cancer Res; 2004 Aug; 64(16):5818-24. PubMed ID: 15313925
[TBL] [Abstract][Full Text] [Related]
11. A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways.
Byun HJ; Hong IK; Kim E; Jin YJ; Jeoung DI; Hahn JH; Kim YM; Park SH; Lee H
J Biol Chem; 2006 Nov; 281(46):34833-47. PubMed ID: 16984917
[TBL] [Abstract][Full Text] [Related]
12. c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells.
Madeo A; Vinciguerra M; Lappano R; Galgani M; Gasperi-Campani A; Maggiolini M; Musti AM
Oncogene; 2010 Feb; 29(7):978-91. PubMed ID: 19935718
[TBL] [Abstract][Full Text] [Related]
13. Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer.
Leupold JH; Asangani I; Maurer GD; Lengyel E; Post S; Allgayer H
Mol Cancer Res; 2007 May; 5(5):485-96. PubMed ID: 17510314
[TBL] [Abstract][Full Text] [Related]
14. Gene Knockdown by EpCAM Aptamer-siRNA Chimeras Suppresses Epithelial Breast Cancers and Their Tumor-Initiating Cells.
Gilboa-Geffen A; Hamar P; Le MT; Wheeler LA; Trifonova R; Petrocca F; Wittrup A; Lieberman J
Mol Cancer Ther; 2015 Oct; 14(10):2279-91. PubMed ID: 26264278
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of EpCAM enhances the chemosensitivity of breast cancer cells to 5-fluorouracil by downregulating the antiapoptotic factor Bcl-2.
Gao J; Yan Q; Liu S; Yang X
PLoS One; 2014; 9(7):e102590. PubMed ID: 25019346
[TBL] [Abstract][Full Text] [Related]
16. Effects of EpCAM overexpression on human breast cancer cell lines.
Gostner JM; Fong D; Wrulich OA; Lehne F; Zitt M; Hermann M; Krobitsch S; Martowicz A; Gastl G; Spizzo G
BMC Cancer; 2011 Jan; 11():45. PubMed ID: 21281469
[TBL] [Abstract][Full Text] [Related]
17. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo.
Schiff R; Reddy P; Ahotupa M; Coronado-Heinsohn E; Grim M; Hilsenbeck SG; Lawrence R; Deneke S; Herrera R; Chamness GC; Fuqua SA; Brown PH; Osborne CK
J Natl Cancer Inst; 2000 Dec; 92(23):1926-34. PubMed ID: 11106684
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-22 promotes epithelial cell transformation and breast tumorigenesis via MAP3K8 activation.
Kim K; Kim G; Kim JY; Yun HJ; Lim SC; Choi HS
Carcinogenesis; 2014 Jun; 35(6):1352-61. PubMed ID: 24517997
[TBL] [Abstract][Full Text] [Related]
20. EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer.
Subramanian N; Kanwar JR; Kanwar RK; Sreemanthula J; Biswas J; Khetan V; Krishnakumar S
PLoS One; 2015; 10(7):e0132407. PubMed ID: 26176230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]